1H-Isoindole-1,3(2H)-dione, 4-[(2-aminoethyl)amino]-2-(2,6-dioxo-3-piperidinyl)- - Names and Identifiers
1H-Isoindole-1,3(2H)-dione, 4-[(2-aminoethyl)amino]-2-(2,6-dioxo-3-piperidinyl)- - Physico-chemical Properties
Molecular Formula | C15H16N4O4
|
Molar Mass | 316.31 |
Density | 1.496±0.06 g/cm3(Predicted) |
Boling Point | 633.6±55.0 °C(Predicted) |
pKa | 10.74±0.40(Predicted) |
1H-Isoindole-1,3(2H)-dione, 4-[(2-aminoethyl)amino]-2-(2,6-dioxo-3-piperidinyl)- - Introduction
4-((2-aminoethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione is an organic compound with the chemical formula C16H17N5O4.
Nature:
-Appearance: White crystalline solid
-Melting point: approximately 160-162°C
-Solubility: Dissolved in some organic solvents, such as dimethyl sulfoxide, ethanol, formic acid, etc.
Use:
-Drug research: The compound has potential anti-tumor activity and is used as a target molecule in drug research and development.
-Photosensitizer: 4-((2-aminoethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione can also be used as a photosensitizer for photosensitive polymerization and other photosensitive applications.
Preparation Method:
At present, there is no detailed publication on the preparation method of the compound.
Safety Information:
-Safety information and toxicity data for 4-((2-aminoethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione are limited due to lack of published literature.
-For all chemicals, carefully read and understand the relevant safety technical instructions before use, follow correct operating procedures, and wear appropriate personal protective equipment.
-If you need to use the compound, please follow the laboratory's safe operating procedures, and properly store and dispose of chemical waste. Maintain proper ventilation during use and avoid direct contact with skin, eyes and inhalation of gases.
Please note that this is only an overview based on available information and that accurate nature, use, formulation and safety information requires further reference to authoritative literature or professional consultation.
Last Update:2024-04-09 19:05:53